Precigen (PGEN) Amortization of Deferred Charges (2018 - 2026)
Precigen (PGEN) posted quarterly Amortization of Deferred Charges of $345000.0 for Q1 2026, up 21.48% quarter-over-quarter from $284000.0 in Q4 2025.
Analysis
Precigen (PGEN) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends
Precigen (PGEN) has reported Amortization of Deferred Charges for 8 consecutive years, with $345000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $345000.0; the TTM figure through Mar 2026 stood at $629000.0 (changed N/A YoY), while the FY2025 annual figure was $356000.0, changed N/A from the prior year.
- Amortization of Deferred Charges climbed to $345000.0 in Q1 2026 per PGEN's latest filing, from $284000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $345000.0 in Q1 2026 and bottomed at $26000.0 in Q2 2023.
- Historically, Amortization of Deferred Charges has averaged $216375.0 across 4 years, with a median of $284000.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges tumbled 96.51% — and 2023, when it slumped 88.03%.
- Precigen's Amortization of Deferred Charges stood at $108000.0 in 2022, then sank by 75.93% to $26000.0 in 2023, then jumped by 992.31% to $284000.0 in 2025, then increased by 21.48% to $345000.0 in 2026.
- Business Quant data shows PGEN's Amortization of Deferred Charges at $345000.0 in Q1 2026, $284000.0 in Q4 2025, and $26000.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 361,000.00 |
| Mar 31, 2026 | 345,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | 108,000.00 |
| Sep 30, 2022 | 338,000.00 |
| Jun 30, 2022 | 312,000.00 |
| Mar 31, 2022 | 284,000.00 |
| Dec 31, 2021 | 3.09 Mn |
| Sep 30, 2021 | 3.01 Mn |
| Jun 30, 2021 | 2.88 Mn |
| Mar 31, 2021 | 2.75 Mn |
| Dec 31, 2020 | 2.78 Mn |
| Sep 30, 2020 | 2.71 Mn |
| Jun 30, 2020 | 2.58 Mn |
| Mar 31, 2020 | 2.52 Mn |
| Dec 31, 2019 | 2.50 Mn |
| Sep 30, 2019 | 2.43 Mn |